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688a Wednesday, February 6, 2013and translocation as described here to earlier attempts to produce giant proteo-
liposomes is that all proteins are built into the vesicle membrane in the correct
orientation. Our novel cell model opens up the possibility to study e.g. protein
synthesis in vitro with single-molecule microscopy.
[1] S. Fenz, R. Sachse, S. Kubick and T. Schmidt; BPJ 2012, 102(3), pp18a
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Artificial lipid bilayers are well established for use in scientific studies of recon-
stituted ion channels and as a platform to host engineered pore proteins for
sensing, including DNA sequencing. Droplet bilayers have recently been
shown to be especially compatible with technological applications, with re-
cently demonstrated automation, parallelization, and ion channel drug potency
measurements. To expand the range of potential applications, we have been
working to simplify droplet bilayer formation and ion channel measurement.
We have developed a chip for droplet bilayer formation and measurement
that only requires fluid dispensation. Using an array design of this chip, 32
bilayers were simultaneously formed with no operator feedback at a yield of
approximately 80%. Cycling this process resulted in the formation and mea-
surement of 96/120 bilayers in 80 minutes, a rate which could greatly increase
with automation and greater parallelization. We also used these arrays to mea-
sure the a-hemolysin and VDAC channels.
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Hyrophobic-hydrophilic interfaces such as the water-vapor or other liquid-
liquid or solid-liquid interfaces have large effects on the secondary structure
formation and aggregation processes of amphiphilic peptides. Due to the
dual nature of these peptides, they are surface active or tend to self assemble
to minimize the exposed fraction of unsolvable surface. In our study, we
investigate representatives of two different families of amphiphilic peptides
in solution and at the vapor-water interface: b-sheet forming peptides (con-
taining repetitive sequences of hydrophobic/hydrophilic residues), which
self-assemble into monolayers at the airwater interface [1], and an anionic
a-helical amphiphilic cell penetrating peptide (CPP) [2]. The aggregated acidic
b-sheet peptides can serve as a template to promote mineralization processes
taking place at an interface. Whereas the studied CPP GALA belongs to a rel-
atively small class of anionic helix building peptides. The CPPs are promising
tools for targeting intracellular proteins and might be useful in the development
of new delivery systems for therapeutics. We investigate the coupling between
secondary structure formation, partitioning at the interface, and self-
aggregation at the microscopic level in atomistic molecular dynamics simula-
tions with the aim of gaining insight into the interactions which govern the
structure formation at the local scale. Since processes taking place at longer
time scales or larger system sizes are hardly accessible to atomistic simulations,
we utilize the information gathered from atomistic simulations to develop
a fragment-based coarse-grained model which can be applied to inhomoge-
neous systems with interfaces.
1. Rapaport, H., Grisaru, H. and Silberstein, T., Adv. Funct. Mater. 18, 2889-
2896 (2008)
2. Lia W., Nicol F. and Szoka Jr., F.C., Adv. Drug Deliv. Rev. 56, 967-985
(2004)
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Delivery of drugs across Blood-brain barrier (BBB) can be enhanced by phys-
ical stimulation (e.g. ultrasound). When BBB is opened by ultrasound sonica-
tion in the presence of microbubbles, its vascular permeability will decay due toBBB repairing. The transport and accumulation of nanodrugs in brain tissue is
affected by both physicochemical properties of drugs and closure dynamics of
BBB. In this study, we developed a mathematical model and employed animal
experiments to investigate the impact of recovery of disrupted BBB on nano-
drug delivery into brain tissue. We chose Evans blue (EB)-albumin complexes
as a model nanodrug and studied the effects of initial permeability, decaying
speed of permeability and half-life of EB-albumin complexes on their
spatial-temporal concentration response and accumulation in brain tissue.
The transport parameters used in this model were obtained from previously
published studies and the fitting of our experimental data with Particle Swarm
Optimization (PSO). The simulation results showed that there exists optimal
initial permeability and decaying speed of permeability to achieve a maximum
AUC (area under the concentration-time curve) of EB-albumin in the brain tis-
sue. The results indicate that we can enhance the accumulation of nanodrugs
safely in brain tissue by controlling the recovery dynamics of BBB opening.
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Knowledge of the dielectric properties of body fluids such as blood, urine, and
sweat can provide information on their water and glucose contents. This infor-
mation is particularly important for monitoring glucose level in individuals
who suffer from diabetes. We measured the dielectric constant, dielectric
loss factor, and alternating current (ac) conductivity for various concentrations
of sucrose solutions ranging from 0.1 to 1M. We also measured urine samples
from diabetics. We used an Agilent E5071C Network Analyzer coupled to a Di-
electric probe for measurements between 100 and 3000 MHz frequency range
at an average room temperature of 22.55 0.5 o C. Results show a gradual de-
crease in dielectric constant with molarity over the frequency range covered.
The dielectric loss factor and the ac conductivity both showed steady increases
with molarity. Results for pre-meal and post-meal urine samples from diabetic
individuals showed increases in dielectric loss and ac conductivity in post-meal
samples. These increases were attributed to higher glucose level in post-meal
urine. This work suggests that dielectric data could be useful in monitoring glu-
cose level in diabetics.
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OxyVita, Inc. has developed proprietary technology to lyophilize a next gen-
eration Hemoglobin-Based-Oxygen-Carrier (HBOC) and coagulation compo-
nents (plasma and platelets) without altering the specific properties of these
components. The average molecular weight (17MDa) and hydrodynamic ra-
dius (36nm) of the OxyVita C polymers are similar to the solution form
from which the powder is produced, indicating no protein dissociation or un-
folding during lyophilization. The reconstitution of OxyVita C powder is ~15
sec. in water. The liquid form of this HBOC is currently in pre-clinical studies
as a dedicated oxygen delivery protein. The proprietary process which affords
specific molecular protection to OxyVita C has now been applied to protect
lyophilized human coagulation components (plasma and/or platelets). Natural
platelets have a shelf life limited of 5 days. By implementing this protection
technology, it is possible to extend the storage of freeze-dried platelets for at
least 30 days, maintaining functionality as evident from repeated coagulation
studies using a PAP-8 analyzer (Bio-Data).These studies exhibited the same
coagulation capacity as fresh plasma or platelets (~78%) using a PAP-8 ana-
lyzer. After 30 days of powder storage, a decrease of only 7% activity was
observed. Solubility of the powder platelets was ~10 sec. Reconstitution in
different (IV) fluids has been shown in vitro with these preparations. Con-
sistent results with 6 batches of powder plasma and 12 batches of powder
platelets produced to date have been observed. Availability of each product
provides flexibility for an appropriate treatment mode for a clinical situation,
allowing: 1) only use the oxygen delivery component (OxtVita C) in the pow-
der form; 2) a combination of OxyVit C with coagulation capacity (multifunc-
tional resuscitation fluid); or 3) only coagulation enhancement using either
dried plasma or platelets.
